Checkpoint NOW

Nov 12 2024 30 ep. 26 mins 6
Checkpoint NOW Podcast artwork

All you need to know about the latest evidence based practice in the diagnosis and management of immune related toxicities from cancer therapies straight from the experts in the field.

  Health & Fitness
RSS feed Share
Copy RSS


Subscribe on Podcast Addict


Episode 29: Balancing conversations about toxicities

Nov 12 2024 53 mins  
Join hosts Drs. Afreen Shariff and Pauline Funchain as they discuss with health care communications expert Dr. Timothy Gilligan from Cleveland Clinic about the delicate balance between the fear of toxicities and providing meaningful information for patients and caregivers so they feel empowered and engaged.

Episode 28: Alliance Clinical Trial for Immune Mediated toxicities

Oct 07 2024 21 mins  
Join hosts Dr. Afreen Shariff and Dr. Pauline Funchain as they discuss with Dr. David Kozono, a radiation oncologist at Dana Farber Cancer Institute and the chair of the ALLIANCE clinical trial to set up a national Biorepository to Study Immunotherapy Side Effects. https://www.allianceforclinicaltrialsinoncology.org/main/public/standard.xhtml?path=/Public/News-A151804-Oct2020

Episode 27: ASPirE- The International Alliance for Support and Prevention of immune related Events

Aug 19 2024 52 mins  
Join the Executive Committee of ASPirE- Dr. Afreen Shariff, Dr. Pauline Funchain, Dr. Kerry Reynolds, Dr. Alexa Meara and Dr. Elad Sharon as they discuss the new international Initiative that brings clinicians, educators, researchers and patients together to inform science and clinical innovation in irAEs.

Episode 26: Cancer treatments and the Heart

Aug 13 2024 45 mins  
Learn about the effect of cancer treatments on the heart. Who needs to see a cardiologist before, during and after cancer treatment- the When and Why with oncologist Dr. Susan Dent and cardio oncologist Dr. Robert Copeland-Halperin.

Episode 25: Adrenal Insufficiency- What patients need to know.

Jul 07 2024 46 mins  
Join Dr. Afreen Shariff and Dr. Pauline Funchain as they break down Adrenal Insufficiency from cancer treatments in simple terms for patients, caregivers and care teams.

Episode 24: Costs of adverse events in Renal Cell Carcinoma

Oct 23 2023 25 mins  
Learn from the experts about the costs associated with irAEs in patients treated for Renal Cell Carcinoma. Join our hosts Dr. Afreen Shariff and Dr. Tian Zhang as they discuss with guest experts- medical Oncologists Dr. Daniel Geynisman and Dr. Bradley McGregor, MD for an informative and high yield discussion regarding real and hidden costs of adverse events and how this impacts pa

Episode 23: Emotional impact of side effects on patients and caregivers

May 17 2023 30 mins  
Join host Dr. Afreen Shariff and Dr. Tian Zhang as they discuss with guest expert and Psychologist, Dr. Rebecca Shelby about the emotional impacts like stress, depression, and anxiety associated with side effects from cancer treatments.

Episode 22: Germline Variants, Toxicities and ICI

Apr 13 2023 18 mins  
Join our hosts Dr. Afreen Shariff and Dr. Tian Zhang as they discuss with guest experts from Dana Farber Cancer Institute, GU Oncologist Dr. Toni Choueiri and Quantitative Geneticist Dr. Sasha Gusev as they discuss Germline variants associated with immune checkpoint blockade and associated irAEs.

Episode 21: Thyroid disease in cancer patients. What you need to know as a patient!

Nov 27 2022 14 mins  
Hosts: Join our hosts Dr. Afreen Shariff and Dr. Tian Zhang as they discuss with guest experts and thyroidologists Dr. Trevor Angell and Dr. Anupam Kotwal as they discuss information regarding thyroid disease in cancer patients for patients and caregivers.

Episode 20: Patient experience, advocacy and immune toxicities

Sep 25 2022 33 mins  
Join our hosts Dr. Afreen Shariff and Dr. Tian Zhang as they discuss with Dena Battle from KCCure- an evidence based, patient driven advocacy organization. Dena shares her deep insight on patient, caregiver experiences around toxicity management and how we can learn from each other to improve patient outcomes.